|
Diabetes Care, Vol 22, Issue 7 1196-1200, Copyright © 1999 by American Diabetes Association
Bone mineral density in patients with type 1 and type 2 diabetes
JT Tuominen, O Impivaara, P Puukka and T Ronnemaa
Department of Medicine, University of Turku, Finland.
OBJECTIVE: To assess the effect of type 1 and type 2 diabetes and insulin
treatment on bone mineral density (BMD) in middle-aged and elderly men and
women. RESEARCH DESIGN AND METHODS: We measured BMD and evaluated known
determinants of osteoporosis in 56 type 1 and 68 type 2 diabetic patients
and 498 nondiabetic community control subjects. All patients, aged 52-72
years, developed diabetes after the age of 30 years (i.e., after
achievement of peak bone mass) and were treated with insulin. BMD was
measured at the proximal femur with dual-energy X-ray absorptiometry.
RESULTS: Among both sexes, BMD values were significantly lower in type 1
diabetic patients than in type 2 diabetic patients or the control subjects.
When adjusted for age and BMI, the differences between type 1 diabetic
patients and control subjects remained essentially unchanged in both sexes,
whereas the differences between type 1 and type 2 diabetic subjects were
significant only in men. After further adjustments for confounding factors,
the average BMD values were still lower in type 1 diabetic subjects than in
type 2 diabetic subjects although with lesser significance. Past low-energy
fractures were more common in type 1 diabetic women than in type 2 diabetic
women. CONCLUSIONS: The lower BMD in type 1 versus type 2 diabetic patients
and control subjects probably results from more rapid bone loss after the
onset of type 1 diabetes. This cannot be explained by insulin treatment,
which was prescribed for both types of patients. Because the causes of low
BMD in type 1 diabetes are unknown, these patients should be evaluated for
the risk of osteoporosis and related fractures and offered appropriate
preventive measures.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Fowlkes, R. C. Bunn, L. Liu, E. C. Wahl, H. N. Coleman, G. E. Cockrell, D. S. Perrien, C. K. Lumpkin Jr., and K. M. Thrailkill
Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus
Endocrinology,
April 1, 2008;
149(4):
1697 - 1704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Holmberg, P. M. Nilsson, J-A. Nilsson, and K. Akesson
The Association between Hyperglycemia and Fracture Risk in Middle Age. A Prospective, Population-Based Study of 22,444 Men and 10,902 Women
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
815 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamamoto, T. Yamaguchi, M. Yamauchi, S. Yano, and T. Sugimoto
Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
1013 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Monami, B. Cresci, A. Colombini, L. Pala, D. Balzi, F. Gori, V. Chiasserini, N. Marchionni, C. M. Rotella, and E. Mannucci
Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients: A case-control study
Diabetes Care,
February 1, 2008;
31(2):
199 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Janghorbani, R. M. Van Dam, W. C. Willett, and F. B. Hu
Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture
Am. J. Epidemiol.,
September 1, 2007;
166(5):
495 - 505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Skedros, C. L. Sybrowsky, and G. J. Stoddard
The Osteoporosis Self-Assessment Screening Tool: A Useful Tool for the Orthopaedic Surgeon
J. Bone Joint Surg. Am.,
April 1, 2007;
89(4):
765 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dowell, T. W. Oates, and M. Robinson
Implant success in people with type 2 diabetes mellitus with varying glycemic control: A pilot study
J Am Dent Assoc,
March 1, 2007;
138(3):
355 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Botolin and L. R. McCabe
Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice
Endocrinology,
January 1, 2007;
148(1):
198 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Endocrinology,
December 1, 2006;
147(12):
5760 - 5767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Bonds, J. C. Larson, A. V. Schwartz, E. S. Strotmeyer, J. Robbins, B. L. Rodriguez, K. C. Johnson, and K. L. Margolis
Risk of Fracture in Women with Type 2 Diabetes: the Women's Health Initiative Observational Study
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3404 - 3410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Janghorbani, D. Feskanich, W. C. Willett, and F. Hu
Prospective Study of Diabetes and Risk of Hip Fracture: The Nurses' Health Study
Diabetes Care,
July 1, 2006;
29(7):
1573 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Strotmeyer, J. A. Cauley, T. J. Orchard, A. R. Steenkiste, and J. S. Dorman
Middle-Aged Premenopausal Women With Type 1 Diabetes Have Lower Bone Mineral Density and Calcaneal Quantitative Ultrasound Than Nondiabetic Women
Diabetes Care,
February 1, 2006;
29(2):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Miao, K. Brismar, O. Nyren, A. Ugarph-Morawski, and W. Ye
Elevated Hip Fracture Risk in Type 1 Diabetic Patients: A Population-Based Cohort Study in Sweden
Diabetes Care,
December 1, 2005;
28(12):
2850 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Am J Physiol Endocrinol Metab,
November 1, 2005;
289(5):
E735 - E745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Thrailkill, L. Liu, E. C. Wahl, R. C. Bunn, D. S. Perrien, G. E. Cockrell, R. A. Skinner, W. R. Hogue, A. A. Carver, J. L. Fowlkes, et al.
Bone Formation Is Impaired in a Model of Type 1 Diabetes
Diabetes,
October 1, 2005;
54(10):
2875 - 2881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Botolin, M.-C. Faugere, H. Malluche, M. Orth, R. Meyer, and L. R. McCabe
Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-{gamma}2 Expression in Type I Diabetic Mice
Endocrinology,
August 1, 2005;
146(8):
3622 - 3631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D J Hadjidakis, A M Mylonakis, M E Sfakianakis, A E Raptis, and S A Raptis
Diabetes and premature menopause: is their co-existence detrimental to the skeleton?
Eur. J. Endocrinol.,
March 1, 2005;
152(3):
437 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kemmis and D. Stuber
Diabetes and Osteoporotic Fractures: The Role of the Diabetes Educator
The Diabetes Educator,
March 1, 2005;
31(2):
187 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K Hastings, D. R Sinacore, F. A Fielder, and J. E Johnson
Bone Mineral Density During Total Contact Cast Immobilization for a Patient With Neuropathic (Charcot) Arthropathy
Physical Therapy,
March 1, 2005;
85(3):
249 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Mollard, M. E. Gillam, T. M. Wood, C. G. Taylor, and H. A. Weiler
(n-3) Fatty Acids Reduce the Release of Prostaglandin E2 from Bone but Do Not Affect Bone Mass in Obese (fa/fa) and Lean Zucker Rats
J. Nutr.,
March 1, 2005;
135(3):
499 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Brown and J. L. Sharpless
Osteoporosis: An Under-appreciated Complication of Diabetes
Clin. Diabetes,
January 1, 2004;
22(1):
10 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. He, R. Liu, T. Desta, C. Leone, L. C. Gerstenfeld, and D. T. Graves
Diabetes Causes Decreased Osteoclastogenesis, Reduced Bone Formation, and Enhanced Apoptosis of Osteoblastic Cells in Bacteria Stimulated Bone Loss
Endocrinology,
January 1, 2004;
145(1):
447 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. M. Dhonukshe-Rutten, M. Lips, N. de Jong, M. J. M. Chin A Paw, G. J. Hiddink, M. van Dusseldorp, L. C. P. G. M. de Groot, and W. A. van Staveren
Vitamin B-12 Status Is Associated with Bone Mineral Content and Bone Mineral Density in Frail Elderly Women but Not in Men
J. Nutr.,
March 1, 2003;
133(3):
801 - 807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G K T Holmes
Screening for coeliac disease in type 1 diabetes
Arch. Dis. Child.,
December 1, 2002;
87(6):
495 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Q. Ivers, R. G. Cumming, P. Mitchell, and A. J. Peduto
Diabetes and Risk of Fracture: The Blue Mountains Eye Study
Diabetes Care,
July 1, 2001;
24(7):
1198 - 1203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Schwartz, D. E. Sellmeyer, K. E. Ensrud, J. A. Cauley, H. K. Tabor, P. J. Schreiner, S. A. Jamal, D. M. Black, and S. R. Cummings
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
J. Clin. Endocrinol. Metab.,
January 1, 2001;
86(1):
32 - 38.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Jorgensen, T. Engstad, and B. K. Jacobsen
Bone Mineral Density in Acute Stroke Patients : Low Bone Mineral Density May Predict First Stroke in Women
Stroke,
January 1, 2001;
32(1):
47 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|